Equities

CARsgen Therapeutics Holdings Ltd

CARsgen Therapeutics Holdings Ltd

Actions
  • Price (USD)0.76
  • Today's Change0.00 / 0.00%
  • Shares traded2.00k
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Jun 14 2024 14:30 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments1,8502,2683,007
Total Receivables, Net121749
Total Inventory0.68----
Prepaid expenses9.719.729.57
Other current assets, total1.136.315.30
Total current assets1,8732,3013,071
Property, plant & equipment, net361441386
Goodwill, net------
Intangibles, net8.661420
Long term investments------
Note receivable - long term------
Other long term assets146.3228
Total assets2,2572,7633,506
LIABILITIES
Accounts payable------
Accrued expenses15113794
Notes payable/short-term debt000
Current portion long-term debt/capital leases1522233
Other current liabilities, total311261
Total current liabilities196171389
Total long term debt7097105
Total debt85119338
Deferred income tax------
Minority interest------
Other liabilities, total1892115
Total liabilities456290509
SHAREHOLDERS EQUITY
Common stock0.000.000.00
Additional paid-in capital9,4379,4309,420
Retained earnings (accumulated deficit)(8049)(7316)(6468)
Treasury stock - common0----
Unrealized gain (loss)------
Other equity, total41435944
Total equity1,8022,4732,997
Total liabilities & shareholders' equity2,2572,7633,506
Total common shares outstanding576573568
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.